<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518139</url>
  </required_header>
  <id_info>
    <org_study_id>0128</org_study_id>
    <nct_id>NCT02518139</nct_id>
  </id_info>
  <brief_title>A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>A Phase 3, 52-week, Randomized, Active−Controlled Parallel Group Study to Evaluate the Safety and Tolerability of Nebulized TD−4208 in Subjects With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theravance Biopharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theravance Biopharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the safety and tolerability of TD 4208, an
      investigational drug being developed to treat people with moderate to very severe COPD,
      compared to tiotropium.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events: Frequency and Severity</measure>
    <time_frame>Baseline to Day 365</time_frame>
    <description>To assess the safety and tolerability of TD-4208 by assessing the frequency and severity of Treatment Emergent Adverse Events (TEAE)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1060</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>TD-4208-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>88 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TD-4208-2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>175 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tiotropium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>18 mcg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TD-4208</intervention_name>
    <description>Subjects receiving TD-4208 are blinded to one of two doses of 4208.</description>
    <arm_group_label>TD-4208-1</arm_group_label>
    <arm_group_label>TD-4208-2</arm_group_label>
    <other_name>revefenacin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tiotropium</intervention_name>
    <description>There is not a placebo, there is an active comparator (Tiotropium) arm.</description>
    <arm_group_label>Tiotropium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is a male or female subject 40 years of age or older

        Exclusion Criteria:

          -  Females who are pregnant, lactating, breast-feeding or planning to become pregnant
             during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Theravance Biopharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Palmetto Medical Research Associates L.L.C</name>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <zip>29640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>August 5, 2015</study_first_submitted>
  <study_first_submitted_qc>August 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2015</study_first_posted>
  <results_first_submitted>December 6, 2018</results_first_submitted>
  <results_first_submitted_qc>December 6, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 31, 2018</results_first_posted>
  <disposition_first_submitted>April 13, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>April 13, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 17, 2018</disposition_first_posted>
  <last_update_submitted>January 26, 2019</last_update_submitted>
  <last_update_submitted_qc>January 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease, COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tiotropium Bromide</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 13, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT02518139/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 21, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT02518139/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>TD-4208-1</title>
          <description>88 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="P2">
          <title>TD-4208-2</title>
          <description>175 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="P3">
          <title>Tiotropium</title>
          <description>18 mcg
Tiotropium: Active comparator</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="364"/>
                <participants group_id="P2" count="335"/>
                <participants group_id="P3" count="356"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="219"/>
                <participants group_id="P2" count="191"/>
                <participants group_id="P3" count="262"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="145"/>
                <participants group_id="P2" count="144"/>
                <participants group_id="P3" count="94"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>1060 subjects were randomized. A total of 1055 subjects received at least one dose of study drug.</population>
      <group_list>
        <group group_id="B1">
          <title>TD-4208-1</title>
          <description>88 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="B2">
          <title>TD-4208-2</title>
          <description>175 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="B3">
          <title>Tiotropium</title>
          <description>18 mcg
Tiotropium: Active comparator</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="364"/>
            <count group_id="B2" value="335"/>
            <count group_id="B3" value="356"/>
            <count group_id="B4" value="1055"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                    <measurement group_id="B2" value="167"/>
                    <measurement group_id="B3" value="163"/>
                    <measurement group_id="B4" value="513"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="181"/>
                    <measurement group_id="B2" value="168"/>
                    <measurement group_id="B3" value="193"/>
                    <measurement group_id="B4" value="542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.1" spread="9.36"/>
                    <measurement group_id="B2" value="64.4" spread="8.61"/>
                    <measurement group_id="B3" value="64.9" spread="8.91"/>
                    <measurement group_id="B4" value="64.4" spread="8.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="142"/>
                    <measurement group_id="B4" value="439"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="206"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="214"/>
                    <measurement group_id="B4" value="616"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="357"/>
                    <measurement group_id="B2" value="326"/>
                    <measurement group_id="B3" value="352"/>
                    <measurement group_id="B4" value="1035"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="69"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="337"/>
                    <measurement group_id="B2" value="309"/>
                    <measurement group_id="B3" value="331"/>
                    <measurement group_id="B4" value="977"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="364"/>
                    <measurement group_id="B2" value="335"/>
                    <measurement group_id="B3" value="356"/>
                    <measurement group_id="B4" value="1055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Current Smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="171"/>
                    <measurement group_id="B2" value="151"/>
                    <measurement group_id="B3" value="167"/>
                    <measurement group_id="B4" value="489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Former Smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                    <measurement group_id="B2" value="184"/>
                    <measurement group_id="B3" value="189"/>
                    <measurement group_id="B4" value="566"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Adverse Events: Frequency and Severity</title>
        <description>To assess the safety and tolerability of TD-4208 by assessing the frequency and severity of Treatment Emergent Adverse Events (TEAE)</description>
        <time_frame>Baseline to Day 365</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TD-4208-1</title>
            <description>88 mcg
TD-4208</description>
          </group>
          <group group_id="O2">
            <title>TD-4208-2</title>
            <description>175 mcg
TD-4208</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium</title>
            <description>18 mcg
Tiotropium: Active comparator</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events: Frequency and Severity</title>
          <description>To assess the safety and tolerability of TD-4208 by assessing the frequency and severity of Treatment Emergent Adverse Events (TEAE)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="364"/>
                <count group_id="O2" value="335"/>
                <count group_id="O3" value="356"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adverse Event (AE)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="272"/>
                    <measurement group_id="O2" value="242"/>
                    <measurement group_id="O3" value="275"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate or Severe AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="226"/>
                    <measurement group_id="O2" value="174"/>
                    <measurement group_id="O3" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="43"/>
                    <measurement group_id="O3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded from signing of the ICF through the final follow-up assessment (approximately 1 year)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>TD-4208-1</title>
          <description>88 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="E2">
          <title>TD-4208-2</title>
          <description>175 mcg
TD-4208: There is not a placebo, there is a comparator (Tiotropium) arm, and the subjects are blinded to one of two doses of 4208 or un-blinded to Tiotropium.</description>
        </group>
        <group group_id="E3">
          <title>Tiotropium</title>
          <description>18 mcg
Tiotropium: Active comparator</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 18.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="364"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="335"/>
                <counts group_id="E3" subjects_affected="58" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="364"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Small initestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Fungaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Ludwig angina</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Peritoneal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Near drowning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Brain cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Colon cancer stage 0</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Ear neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Laryngeal squamouse cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Ureteric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Bipolar I disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="364"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="364"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pulmonary granuloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="364"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA 18.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="202" subjects_at_risk="364"/>
                <counts group_id="E2" subjects_affected="166" subjects_at_risk="335"/>
                <counts group_id="E3" subjects_affected="188" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="364"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="364"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="364"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="28" subjects_affected="28" subjects_at_risk="364"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="335"/>
                <counts group_id="E3" events="17" subjects_affected="17" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="364"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E3" events="24" subjects_affected="24" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="364"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="364"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="335"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="364"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="364"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Anthralgia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="364"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="364"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="107" subjects_affected="107" subjects_at_risk="364"/>
                <counts group_id="E2" events="73" subjects_affected="73" subjects_at_risk="335"/>
                <counts group_id="E3" events="100" subjects_affected="100" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="364"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="335"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="31" subjects_affected="31" subjects_at_risk="364"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="356"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="364"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="364"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E3" events="16" subjects_affected="16" subjects_at_risk="356"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head of Clinical Development &amp; Medical Affairs</name_or_title>
      <organization>Theravance Biopharma</organization>
      <phone>1-855-633-8479</phone>
      <email>medinfo@theravance.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

